chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Hyperhidrosis, Lymphadenopathy, Nasal congestion
Clinical narrative: Stuffy nose; swollen lymph node under armpit of injection arm right arm could not sleep for 3 plus hours due to pain of swollen lymph node; Could not sleep for 3 plus hours; Woke up groggy; Intermittent sweats; overheating; Very tired; Arm/injection site soreness and pain lifting arm above head; Arm/injection site soreness and pain lifting arm above head; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0158) via an unspecified route of administration in the right arm on 14Apr2021 at 13:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and herpes simplex type ii (HSV2). The patient was allergic to sulfa meds. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), clonazepam (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (PROZAC); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the right arm on 25Mar2021 at 13:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, on day 1 of vaccination, the patient felt very tired, arm/injection site soreness, pain lifting arm above head. On 15Apr2021, on day 2 of vaccination, the patient was tired, had intermittent sweats/overheating. The patient had no fever or chills. On evening day 2 the patient fell asleep around 21:00 just tired, awake around 00:30 on 16Apr2021 with stuffy nose and swollen lymph node under armpit of injection arm (right arm); the patient couldn't sleep for 3+ hours due to pain of swollen lymph node, approximately size of clementine; eventually slept again, on day 3, 16Apr2021 the patient woke up groggy, alert but tiring easily as the patient tried to work (computer/office job from home). Lymph node swelling down considerably but not gone and still was painful. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very tired, arm/injection site soreness and pain lifting arm above head, intermittent sweats, overheating, woke up groggy, stuffy nose, swollen lymph node under armpit of injection arm right arm could not sleep for 3 plus hours due to pain of swollen lymph node were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Poor quality sleep, Somnolence, Vaccination site pain
Clinical narrative: Stuffy nose; swollen lymph node under armpit of injection arm right arm could not sleep for 3 plus hours due to pain of swollen lymph node; Could not sleep for 3 plus hours; Woke up groggy; Intermittent sweats; overheating; Very tired; Arm/injection site soreness and pain lifting arm above head; Arm/injection site soreness and pain lifting arm above head; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0158) via an unspecified route of administration in the right arm on 14Apr2021 at 13:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and herpes simplex type ii (HSV2). The patient was allergic to sulfa meds. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), clonazepam (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (PROZAC); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the right arm on 25Mar2021 at 13:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, on day 1 of vaccination, the patient felt very tired, arm/injection site soreness, pain lifting arm above head. On 15Apr2021, on day 2 of vaccination, the patient was tired, had intermittent sweats/overheating. The patient had no fever or chills. On evening day 2 the patient fell asleep around 21:00 just tired, awake around 00:30 on 16Apr2021 with stuffy nose and swollen lymph node under armpit of injection arm (right arm); the patient couldn't sleep for 3+ hours due to pain of swollen lymph node, approximately size of clementine; eventually slept again, on day 3, 16Apr2021 the patient woke up groggy, alert but tiring easily as the patient tried to work (computer/office job from home). Lymph node swelling down considerably but not gone and still was painful. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very tired, arm/injection site soreness and pain lifting arm above head, intermittent sweats, overheating, woke up groggy, stuffy nose, swollen lymph node under armpit of injection arm right arm could not sleep for 3 plus hours due to pain of swollen lymph node were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Heart rate, Heart rate increased, Migraine
Clinical narrative: Fever - began within 12 hours; highest temp recorded was 101; Massive headache/migraine; Rapid heart rate - resting in middle of night was approx. 100bpm and is normally approx. 50-55bpm. Heart rate was elevated above 85bpm for most of the day with low to no movement; Dizziness and hard to talk from heart rate; Hard to talk from heart rate; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 08Apr2021 at 17:00 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included heart condition- congenital pulmonary stenosis and subclinical hypothyroidism. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included etonogestrel (NEXPLANON) and levothyroxine (MANUFACTURER UNKNOWN), all taken from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 18Mar2021 at 17:15 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 02:00, within 12 hours the patient experienced fever; highest temperature recorded was 101-degree, massive headache/migraine and rapid heart rate. Resting in middle of night was approx. 100 bpm and was normally approx. 50-55 bpm. Heart rate was elevated above 85bpm for most of the day with low to no movement. The patient also had dizziness and hard to talk from heart rate. On 09Apr2021 patient checked body temperature and resulted in 101 degree Fahrenheit and checked heart rate which was 100 beats per minute, and 85 beats per minute for most of the day with low or no movement. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever; highest temperature recorded was 101-degree, massive headache/migraine and rapid heart rate. Resting in middle of night was approx. 100 bpm and was normally approx. 50-55 bpm. Heart rate was elevated above 85bpm for most of the day with low to no movement. The patient also had dizziness and hard to talk from heart rate were resolving at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Speech disorder
Clinical narrative: Fever - began within 12 hours; highest temp recorded was 101; Massive headache/migraine; Rapid heart rate - resting in middle of night was approx. 100bpm and is normally approx. 50-55bpm. Heart rate was elevated above 85bpm for most of the day with low to no movement; Dizziness and hard to talk from heart rate; Hard to talk from heart rate; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 08Apr2021 at 17:00 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included heart condition- congenital pulmonary stenosis and subclinical hypothyroidism. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included etonogestrel (NEXPLANON) and levothyroxine (MANUFACTURER UNKNOWN), all taken from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 18Mar2021 at 17:15 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 02:00, within 12 hours the patient experienced fever; highest temperature recorded was 101-degree, massive headache/migraine and rapid heart rate. Resting in middle of night was approx. 100 bpm and was normally approx. 50-55 bpm. Heart rate was elevated above 85bpm for most of the day with low to no movement. The patient also had dizziness and hard to talk from heart rate. On 09Apr2021 patient checked body temperature and resulted in 101 degree Fahrenheit and checked heart rate which was 100 beats per minute, and 85 beats per minute for most of the day with low or no movement. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever; highest temperature recorded was 101-degree, massive headache/migraine and rapid heart rate. Resting in middle of night was approx. 100 bpm and was normally approx. 50-55 bpm. Heart rate was elevated above 85bpm for most of the day with low to no movement. The patient also had dizziness and hard to talk from heart rate were resolving at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Chills; Fever; Body ache; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 10:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date and the patient did not have any other relevant medical history. The patient had no allergies to medications, food, or other products. The patient did not receive any medication within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 14:00, within several hours of vaccine dose, the patient experienced chills, fever and body ache, which lasted for one day and the patient was feeling better. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fever and body ache were resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Pyrexia, Vaccination site pain
Clinical narrative: Sore arm at injection site; Stomach cramps; Low-grade fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 18:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and sesame oil allergy. Concomitant medications included vitamin D nos (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), ubidecarenone (COQ-10) and prenatal vitamin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 17:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Apr2021 at 03:00, the patient experienced sore arm at injection site, stomach cramps and low-grade fever with chills. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sore arm at injection site, stomach cramps and low-grade fever with chills was resolving at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Oropharyngeal pain, Rash, Swollen tongue
Clinical narrative: About 3 hours after getting the vaccine, my tongue started to swell; My throat hurt; My throat hurt as well near the lymph nodes.; rash appeared on my neck; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW01J8) via an unspecified route of administration on 15Apr2021 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, known allergies to latex, pollen and ragweed. Concomitant medications included diphenhydramine, paracetamol, phenylpropanolamine hydrochloride (BENADRYL), fexofenadine hydrochloride (ALLEGRA) and unspecified vitamins; all for unspecified indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 16:30, about 3 hours after getting the vaccine, the patient experienced tongue started to swell and a rash appeared on neck and throat hurt as well near the lymph nodes. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events tongue started to swell and a rash appeared on neck and throat hurt as well near the lymph nodes and included treatment with prednisone. The clinical outcome of the events tongue started to swell and a rash appeared on neck and throat hurt as well near the lymph nodes were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Headache, Migraine
Clinical narrative: Brain fog; Migraine; Night sweats; Headache; Chills; Fever; Tired; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8735) via an unspecified route of administration in the arm left on 08Apr2021 at 11:45 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. On 09Apr2021 at 02:00, the patient experienced brain fog, migraine, night sweats, headache, chills, fever and tired. Therapeutic measures were taken as a result of events and included treatment with TYLENOL. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events brain fog, migraine, night sweats, headache, chills, fever and tired were recovered on an unspecified date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Night sweats, Pyrexia
Clinical narrative: Brain fog; Migraine; Night sweats; Headache; Chills; Fever; Tired; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8735) via an unspecified route of administration in the arm left on 08Apr2021 at 11:45 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. On 09Apr2021 at 02:00, the patient experienced brain fog, migraine, night sweats, headache, chills, fever and tired. Therapeutic measures were taken as a result of events and included treatment with TYLENOL. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events brain fog, migraine, night sweats, headache, chills, fever and tired were recovered on an unspecified date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysgeusia, Fatigue, Nausea, Pain
Clinical narrative: Body aches; Tired; Dizziness; Nausea; Taste metallic; It also felt tingly or spicy sensation; It also felt tingly or spicy sensation; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8733) via an unspecified route of administration in the left arm on 28Mar2021 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluticasone propionate (FLOVENT), olopatadine (MANUFACTURER UNKNOWN) and fluticasone (MANUFACTURER UNKNOWN); all for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 19:30, three hours after the shot, the patient experienced dizziness, nausea. The next day, on 29Mar2021, the patient was nauseated, had body aches and was tired. 1-2 days after, on an unknown date of Mar2021, the patient had a weird taste metallic in mouth and also felt tingly or spicy sensation. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness, nausea, body aches, tired, weird taste metallic in mouth and also felt tingly or spicy sensation was recovered on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Taste disorder
Clinical narrative: Body aches; Tired; Dizziness; Nausea; Taste metallic; It also felt tingly or spicy sensation; It also felt tingly or spicy sensation; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8733) via an unspecified route of administration in the left arm on 28Mar2021 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluticasone propionate (FLOVENT), olopatadine (MANUFACTURER UNKNOWN) and fluticasone (MANUFACTURER UNKNOWN); all for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 19:30, three hours after the shot, the patient experienced dizziness, nausea. The next day, on 29Mar2021, the patient was nauseated, had body aches and was tired. 1-2 days after, on an unknown date of Mar2021, the patient had a weird taste metallic in mouth and also felt tingly or spicy sensation. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness, nausea, body aches, tired, weird taste metallic in mouth and also felt tingly or spicy sensation was recovered on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration in the left arm on 16Apr2021 at 08:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis and allergy to sulfa drugs. Concomitant medications included desvenlafaxine succinate monohydrate (PRISTIQ), bupropion (MANUFACTURER UNKNOWN), drospirenone, ethinylestradiol (GIANVI) and spironolactone (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 11:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 11:00, the patient experienced joint pain several hours after injections. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event joint pain was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Skin discolouration
Clinical narrative: Long event of bruising/ bruises that do not hurt; Big purple spots; This is a spontaneous report from a contactable pharmacist, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on an unknown date and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3249) via an unspecified route of administration in the left arm on 16Jan2021 as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient had no known allergies. On an unknown date in 2021, the patient experienced long event of bruising and bruises that did not hurt and caused big purple spots and lasted for days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were  taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events long event of bruising/ bruises that do not hurt and big purple spots were resolved on an unknown date in 2021.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore arm in day after dose; headaches in day after dose; This is a spontaneous report from a contactable consumer. A male adult patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced sore arm and headaches in day after dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore arm and headaches in day after dose were recovered on an unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Headache, Paraesthesia, Pyrexia
Clinical narrative: Backache; Chills; Slight headache; Feverish; Pins and needles all over body; This is a spontaneous report from a contactable healthcare professional. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:30 hours (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, cholesterol high, COVID-19 infection and right knee replacement. It was unknown if the patient had known allergies to medications, food or other products. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) 40 mg, for unknown indication, from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021 at 12:00, the patient experienced backache, chills, slight headache, feverish and pins and needles all over body. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events backache, chills, slight headache, feverish and pins and needles all over body was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain
Clinical narrative: Soreness in armpit (lymph nodes); This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6204) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021, the patient experienced soreness in armpit (lymph nodes). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the reported events. The clinical outcome of the event soreness in armpit (lymph nodes) was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain
Clinical narrative: Fatigue; Slight headache; Arm sore at injection site; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 12Apr2021 at 11:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 22Mar2021 at 11:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. On 12Apr2021 at 14:45, the patient experienced fatigue which was going on day 4, slight headache and arm sore at injection site which resolved on day 02. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm sore at injection site was resolved on 14Apr2021. The clinical outcome of the events fatigue and slight headache were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Chills, Diarrhoea, Dizziness
Clinical narrative: Fast heartbeat; Dizziness; Weakness / no energy; Diarrhea; Itch; Chills; Headache; Nausea; Eating any little food made me feel as if the food is at the top of my throat; Bodyache; This is a spontaneous report received from a contactable consumer or other non-health care professional (Patient). A 48-years-old female patient received unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on 15Apr2021 08:30 (at the age of 48-year-old) as dose number unknown, single for COVID-19 immunisation. Medical history included depression from an unknown date and unknown if ongoing. The patient previously took COMPAZINE [prochlorperazine edisylate] for hypersensitivity and experienced drug hypersensitivity. The patient received anti depressant within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered: Public Health Clinic/Veterans Administration facility. The patient experienced fast heartbeat, dizziness, weakness / no energy, diarrhoea, itch, chills, headache, nausea, eating any little food made me feel as if the food is at the top of my throat, bodyache on 15Apr2021. The events outcome was recovered with sequel on an unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate increased, Nausea, Pain, Pruritus
Clinical narrative: Fast heartbeat; Dizziness; Weakness / no energy; Diarrhea; Itch; Chills; Headache; Nausea; Eating any little food made me feel as if the food is at the top of my throat; Bodyache; This is a spontaneous report received from a contactable consumer or other non-health care professional (Patient). A 48-years-old female patient received unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on 15Apr2021 08:30 (at the age of 48-year-old) as dose number unknown, single for COVID-19 immunisation. Medical history included depression from an unknown date and unknown if ongoing. The patient previously took COMPAZINE [prochlorperazine edisylate] for hypersensitivity and experienced drug hypersensitivity. The patient received anti depressant within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered: Public Health Clinic/Veterans Administration facility. The patient experienced fast heartbeat, dizziness, weakness / no energy, diarrhoea, itch, chills, headache, nausea, eating any little food made me feel as if the food is at the top of my throat, bodyache on 15Apr2021. The events outcome was recovered with sequel on an unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen lymph nodes in the left inner arm pit/ swollen and non-painful lymph nodes on the left side the neck.; Painful lymph nodes in the left inner arm pit; This is a spontaneous report from a contactable other healthcare professional. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0140), via an unspecified route of administration in left arm on 08Jan2021 (at the age of 27-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0140), via an unspecified route of administration in the right arm on 29Jan2021 at 13:00 (at the age of 27-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. The patient did not receive any other medications in two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received unspecified vaccine within four weeks of vaccination. On 11Jan2021, the patient experienced swollen and painful lymph nodes in the left inner arm pit and also swollen and non-painful lymph nodes on the left side of the neck. All occurred within the first few days after the first vaccination dose. Swollen lymph nodes had not reduced in size (nearing four months later), although pain was gone in a few days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent lab tests and procedures which included blood test (blood work) and the result was normal. The clinical outcome of the events, swollen and painful lymph nodes in the left inner arm pit and swollen and non-painful lymph nodes on the left side of the neck were unknown at the time of reporting.    No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: Several days after the second dose, my apple watch alerted me that my heart rate had sky rocketed to 120bpm for my resting pulse. Typically my heart rate is between 60-70bpm. It's now between 90-110bp; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN8730), via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 26-years-old), as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other medications in two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199), via an unspecified route of administration in the left arm on 08Mar2021 at 14:45 (at the age of 26-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 16:00, several days after the second dose the patient's apple watch alerted her that the heart rate had sky rocketed to 120 beats per minute for the resting pulse. Typically, her heart rate was between 60-70 beats per minute. It was now between 90-110 beats per minute when resting. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event. On 30Mar2021 at 16:00, the patient underwent lab test and procedure which included heart rate and result was shown as 120bpm. On an unknown date, the patient underwent lab test and procedure which included heart rate and result was shown as 90-110 bpm. The clinical outcome of the event heart rate had sky rocketed to 120 beats per minute for her resting pulse, typically, her heart rate was between 60-70 beats per minute, it was now between 90-110 beats per minute was not resolved at the time of reporting.    No follow-up attempts are needed. No further information is expected
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: Injection site pain; Fatigue; fever; chills; headache; body aches; Nausea; vomiting; This is a spontaneous report from a contactable nurse, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 14Apr2021(at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced injection site pain, fatigue, fever, chills, headache, body aches, nausea, vomiting. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events injection site pain, fatigue, fever, chills, headache, body aches, nausea, vomiting was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain, Vomiting
Clinical narrative: Injection site pain; Fatigue; fever; chills; headache; body aches; Nausea; vomiting; This is a spontaneous report from a contactable nurse, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 14Apr2021(at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced injection site pain, fatigue, fever, chills, headache, body aches, nausea, vomiting. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events injection site pain, fatigue, fever, chills, headache, body aches, nausea, vomiting was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise
Clinical narrative: Chills; unwell; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 12Apr2021 at 14:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Other medical history of the patient was not reported.  Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not received any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 12:00,  the patient experienced chills and unwell. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of chills and unwell was recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Tongue discomfort
Clinical narrative: Tongue had numbness peaking at 1/2 hour after injection; Sensation similar to slick plastic later resolving into what a burnt tongue feels like the day after burning.; This is a spontaneous report from a non-contactable consumer, the patient. A 59-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0158) via an unspecified route of administration in the left arm on 15Apr2021 at 11:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had allergy to nightshade family of foods (food allergies), mycin family of antibiotics (antibiotic allergies), and imaging contrast dye (contrast media allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included loratadine (CLARITIN) for unknown indication since an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at the patient experienced tongue numbness peaking at half hour after injection which dissipated 3 hours later, and after 24 hours it was completely gone. The patient did not lose sense of taste and experienced a sensation similar to slick plastic later resolving into what a burnt tongue feels like the day after burning. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the reported events. The clinical outcome of the events tongue numbness and burnt tongue was recovered on 16Apr2021.  No follow-up attempts are possible. No further information is expected.